COVID-19 Rapid Antigen Test Kits bulk supplier for pharma manufacturers

Covid-19 Rapid Antigen Test Kits Suppliers & Bulk Manufacturers

Available Forms: Lateral Flow Assay (LFA) Devices

Available Strengths: 85-97%, with detection of high viral loads

Reference Brands: Flowflex, iHealth(US)

COVID-19 Rapid Antigen Lateral Flow Assay (LFA) devices detect viral proteins in nasal or throat swabs. They provide quick results within 15-30 minutes, enabling prompt detection, isolation, and testing outside laboratories. Benefits include rapid screening, easy self-use, high sensitivity during peak infection, and widespread accessibility worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: COVID-19 rapid antigen test kits, based on lateral flow assay (LFA) devices, are regulated as in vitro diagnostic (IVD) medical devices in the US by the FDA and in the EU via EMA. Approval requires dossiers including clinical performance, safety data, manufacturing standards, and quality controls. The FDA reviews clinical trial and validation data for timely emergency use authorization or full approval, while the EMA ensures compliance with regional safety standards. For dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe use, and broad global availability, enabling rapid COVID-19 screening assistance in healthcare and at-home settings worldwide.

Covid-19 Rapid Antigen Test Kits — third party manufacturing & bulk supply

Covid-19 Rapid Antigen Test Kits is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Covid-19 Rapid Antigen Test Kits is supplied as Lateral Flow Assay (LFA) Devices — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Covid-19 Rapid Antigen Test Kits listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Covid-19 Rapid Antigen Test Kits →

Back to Listing

Frequently Asked Questions

COVID-19 Rapid Antigen Test Kits is listed as Lateral Flow Assay (LFA) Devices in 85-97%, with detection of high viral loads. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

COVID-19 Rapid Antigen Test Kits is referenced against Flowflex, iHealth(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.